Agostini O - Search Results

1

[The need to act together in every way possible: inter-sector action in health and education for children living with the congenital Zika syndrome].

Sá MRC, Vieira ACD, Castro BSM, Agostini O, Smythe T, Kuper H, Moreira MEL, Moreira MCN. Sá MRC, et al. Among authors: agostini o. Cad Saude Publica. 2019 Nov 28;35(12):e00233718. doi: 10.1590/0102-311X00233718. eCollection 2019. Cad Saude Publica. 2019. PMID: 31800795 Free PMC article. Portuguese.

2

When doing research with children means negotiating with adults: backstage of a survey of six-year-olds in schools.

Agostini OS, Moreira MCN. Agostini OS, et al. Cien Saude Colet. 2019 Sep 26;24(10):3753-3762. doi: 10.1590/1413-812320182410.23872017. eCollection 2019. Cien Saude Colet. 2019. PMID: 31577006 Free article. English, Portuguese.

3

The evaluation of a health education campaign on the use of leave from work during pregnancy.

Mastrangelo G, Lange JH, Fadda E, Agostini O, Agnesi R, Bardin A, Cegolon L. Mastrangelo G, et al. Among authors: agostini o. BMC Public Health. 2010 Nov 12;10:694. doi: 10.1186/1471-2458-10-694. BMC Public Health. 2010. PMID: 21073727 Free PMC article.

4

Synthesis and analytical profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.

Agostini O, Bonacchi G, Coppini G, Di Marco G, Paoli P, Toja E. Agostini O, et al. Arzneimittelforschung. 1995 Jun;45(6):684-8. Arzneimittelforschung. 1995. PMID: 7646571

5

A new class of antibronchospastic agents: 7-(2,2-dimethyl)propyl substituted xanthines.

Bonacchi G, Agostini O, Di Marco G, Borgianni M, Ballati L, Boni P, Castellucci A, Evangelista S, Toja E. Bonacchi G, et al. Among authors: agostini o. Farmaco. 1995 May;50(5):333-9. Farmaco. 1995. PMID: 7626168

6

Determination of a new antibronchospastic agent, MX2/120, in guinea pig plasma by high-performance liquid chromatography in a pharmacokinetic study.

Agostini O, Toja E. Agostini O, et al. J Chromatogr B Biomed Appl. 1994 Nov 18;661(2):313-8. doi: 10.1016/0378-4347(94)00339-4. J Chromatogr B Biomed Appl. 1994. PMID: 7894672

7

Metabolism of isbufylline in humans. Isolation, identification, and synthesis of plasma and urine metabolites.

Agostini O, Bonacchi G, Coppini G, Toja E, Triolo A, Manzini S, Pieraccini G, Moneti G. Agostini O, et al. Drug Metab Dispos. 1994 Mar-Apr;22(2):259-68. Drug Metab Dispos. 1994. PMID: 7516853

8

Identification of human urinary metabolites of isbufylline by high-performance liquid chromatography/thermospray mass spectrometry.

Triolo A, Agostini O, Bonelli F. Triolo A, et al. Among authors: agostini o. Biol Mass Spectrom. 1994 Feb;23(2):91-6. doi: 10.1002/bms.1200230208. Biol Mass Spectrom. 1994. PMID: 7510130

9

Physico-chemical properties of the new antibronchospastic agent isbufylline.

Agostini O, Bonacchi G, Dapporto P, Paoli P, Fedi M, Manzini S. Agostini O, et al. Arzneimittelforschung. 1990 Oct;40(10):1089-92. Arzneimittelforschung. 1990. PMID: 1705424

10

Determination of the antihypertensive drug 1-[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxyphenyl) piperazine (IP/66) in rat and human plasma by high-performance liquid chromatography and isotope dilution mass spectrometry.

Agostini O, Moneti G, Bonacchi G, Fedi M, Manzini S. Agostini O, et al. J Chromatogr. 1989 Feb 24;487(2):331-40. doi: 10.1016/s0378-4347(00)83041-8. J Chromatogr. 1989. PMID: 2723000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters